Biomerica, Inc. (BMRA) vs Enlivex Therapeutics Ltd. (ENLV)

A side-by-side comparison of Biomerica, Inc. and Enlivex Therapeutics Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — BMRA vs ENLV

growth of $100 · dividends reinvested · last 10y
BMRA -90.6% (-21.1%/yr)ENLV -100.0% (-54.7%/yr)BMRA compounded faster over this window
Log scale — wide-divergence pair
001101001kStart $10020182020202220242026$9$0
BMRA ENLV

BMRA vs ENLV: by the numbers

  • •BMRA is the larger company ($6M vs $6M market cap).
  • •Both run net losses; ENLV's is the smaller (0.00% vs -84.79% net margin).

Metrics side by side

Valuation

MetricBMRAENLV
P/E ratioN/A0.00
P/S ratio1.44N/A
P/B ratio2.430.00

Profitability

MetricBMRAENLV
Gross margin8.09%0.00%
Operating margin-119.54%0.00%
Net margin-84.79%0.00%
ROE-143.54%105.35%
ROIC-117.93%-0.32%

Growth (annualized)

MetricBMRAENLV
Revenue CAGR (5Y)-9.17%N/A
Total return CAGR (5Y)-46.66%-69.81%

Frequently asked

How have BMRA and ENLV total returns compared?
Over the past 10 years, BMRA delivered -20.93% and ENLV delivered -54.76% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.